Wockhardt planning new funding round moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Wockhardt has two molecules Nafithromycin (WCK 4873) for treating pneumonia and WCK 5222 for urinary tract infection, in development phases, with launched lined up for FY25 and FY26
3P India Equity Fund, managed by Prashant Jain, and Madhusudan Kela s Cohesion MK Best Ideas sub-trust are among those funds that have received 5% or more shares in the Qualified Institutional Placement (QIP) of shares.
Other prominent names like ICICI Prudential, Mirae Asset Management, Tata Indian Opportunities Fund, Invesco India Smallcap Fund, Gagandeep Credit Capital and Subhkam Ventures were also issued shares in Wockhardt s QIP.
Tata Indian Opportunities Fund, Tata Mutual Fund – Tata ELSS Tax Saver Fund, BOFA Securities Europe SA-ODI and Aditya Birla Sun Life Insurance Company Limited have collectively been allotted 50 percent of the issue size, the realty firm said.